FDA inspection
Mylan Laboratories Limited: FDA inspection ending May 15, 2026
FDA inspection 1317114 · Official Action Indicated (OAI) · Nashik
Key facts
| Inspection ID | 1317114 |
|---|---|
| Firm | Mylan Laboratories Limited |
| FEI number | 3005587313 |
| City | Nashik |
| Country | India |
| Fiscal year | 2026 |
| Inspection end date | May 15, 2026 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data